Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Person › Details

Gil Beyen (TiGenix N.V. (Euronext + Nasdaq: TIG))

Beyen, Gil (Erytech 2012– CEO before TiGenix 201112 CBO + before CEO + Co-founder)

 

Organisation Organisation TiGenix N.V. (Euronext + Nasdaq: TIG)
  Group Takeda (Group)
Products Product cancer drug
  Product 2 cell therapy
     

   
Record changed: 2021-01-05

Advertisement

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px


More documents for Gil Beyen


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px




» top